Alexander Nowak
Stock Analyst at Craig-Hallum
(2.72)
# 1,861
Out of 5,124 analysts
46
Total ratings
45.95%
Success rate
7.05%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $105.02 | +2.84% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.92 | +177.78% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $248.74 | -36.88% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.64 | +122.51% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $32.50 | +75.38% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $18.81 | -20.26% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $8.52 | -6.10% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.33 | +672.53% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $23.54 | +112.40% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $13.48 | +1,086.94% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $101.65 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.98 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.55 | +331.37% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $65.28 | +68.50% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.30 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.38 | +12,505.04% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $8.77 | +219.27% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $105.02
Upside: +2.84%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.92
Upside: +177.78%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $248.74
Upside: -36.88%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.64
Upside: +122.51%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $32.50
Upside: +75.38%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $18.81
Upside: -20.26%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $8.52
Upside: -6.10%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.33
Upside: +672.53%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $23.54
Upside: +112.40%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $13.48
Upside: +1,086.94%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $101.65
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.98
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.55
Upside: +331.37%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $65.28
Upside: +68.50%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.30
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.38
Upside: +12,505.04%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $8.77
Upside: +219.27%